Heterocyclic Compound Active Ingredients TRIZ Cases

Alternating dosing and washout periods stabilize mutant enzymes, improve lysosomal trafficking, and reduce substrate buildup.

Double-stranded DNA decoys disrupt herpesvirus transcriptional feedback circuits to inhibit replication and reduce viral load.

Adenine activates AMPK via phosphorylation to increase glucose uptake while reducing COX-2 expression, ROS production, and cancer cell growth.

A single-pill low-dose mix of tadalafil, silodosin, and paroxetine extends ejaculation latency while reducing side effects.

An enteric coating that dissolves at pH 5.5+ shifts benzgalantamine release to the intestine, reducing GI effects while preserving bioavailability.

A supramolecular EXP3174-AHU377 complex improves HFrEF treatment by outperforming physical mixtures and boosting ejection fraction.

Non-hallucinogenic psychedelic analogs boost dendritic spine growth and synaptic protein synthesis for faster brain disorder treatment.

Combining chronotropic compounds raises heart rate and cardiac output while reducing side effects and avoiding pacemaker surgery.

NQ-site ligands alter Phe90 conformation and heme bL–bH electron transfer to selectively raise or lower ROS.

Blocking ANO6 in cancer-associated fibroblasts limits lipid delivery to cancer cells, disrupting metabolic support and reducing tumor growth.

This case uses peripherally acting agents to reduce venoconstriction, lower central venous pressure, and improve exercise capacity in HFpEF.

See how selective RXR agonists avoid RAR-linked inflammation while combining immune modulation with remyelination in multiple sclerosis.

N-carbamoylated urethane compounds suppress microglial activation and neurotoxic mediator production to treat neuroinflammatory diseases.

Administering nitroxide antioxidants to increase SIRT2 gene expression levels in human subjects.

A customizable combination pack organizes multiple medications into distinct compartments for immediate access.

Nitroxide antioxidant increases apoptosis gene expression, restoring cellular homeostasis and reducing autoimmune disease risk.

6-Aminopyridin-3-ol derivatives treat inflammatory bowel disease by inhibiting colitis without the toxicity of existing angiogenesis inhibitors.

Selective small molecule inhibitors target Myc proteins to reduce tumor growth while minimizing side effects on normal tissues.

Quinoline derivatives modulate sarcoplasmic/endoplasmic reticulum Ca2+ ATPase activity to restore cellular homeostasis.

Nitroxide antioxidants reverse age-related gene expression decreases to enhance apoptosis and reduce disease symptoms.

Harmonic oscillation generates a vibrational energy platform in biochemical scaffolds, boosting ATP production and mitochondrial DNA activity.

Gamma-ketoaldehyde scavengers neutralize reactive intermediates to prevent oxidative protein modification.

mTOR inhibitors address drug resistance and toxicity by targeting the mTOR pathway to suppress HIV and inhibit cancer.

Combining purified ibogaine derivatives with specific molar ratios addresses limited clinical effectiveness of single-ingredient treatments.

Cinaciguat targets oxidized soluble guanylate cyclase to clear senescent cells, preventing tumor reemergence after radiation therapy.

Chaperones facilitate intracellular trafficking of oxytocin receptors to the plasma membrane, resolving insufficient receptor localization.

Inhibitor compounds bind P-glycoprotein ATP domains to block drug export, restoring chemotherapeutic efficacy in multidrug-resistant cancers.

Small molecules selectively activate the ATF6 arm of the unfolded protein response to remodel the endoplasmic reticulum proteostasis network.

Eicosapentaenoic acid incorporates into cell membranes to reduce cholesterol domain formation and prevent oxidative modifications of polyunsaturated fatty acids.

Lamotrigine and bupropion address prophylactic effectiveness gaps by suppressing neuronal hyperactivity to reduce vertigo relapse.

Combining COX-2 inhibitors with 20-HETE antagonists minimizes cerebrovascular damage while enhancing anti-tumor efficacy.

Small molecule compounds block the BCL6 BTB lateral groove to inhibit transcriptional repression in diffuse large B-cell lymphoma cells.

An administration-withdrawal cycle improves systolic function while minimizing diastolic impairment in heart failure treatment.

Histidine mediates solubility of high-concentration atipamezole, enabling human administration to reverse xylazine overdose effects.

Inhaled pharmaceutical compositions combine multiple antitussive agents to deliver potent local effects directly to the lungs.

Peptide linkers block P-glycoprotein efflux to increase chemotherapeutic accumulation in cancer cells and enhance brain penetration.

Administering a FOXO1 inhibitor removes nuclear repression of valve genes, restoring lymphatic valve function in congenital lymphedema.

Narrow ibogaine dosage ranges between 1 and 4 mg/kg reduce psychiatric symptoms while minimizing QT interval prolongation risks.

A sexual therapy formulation merges phosphodiesterase-5 inhibitors with libido stimulants to enhance erectile function.

Merging methylxanthines and opiate antitussives in an inhaled composition lowers required doses while reducing side effects.

Preserving chlorogenic acids via pre-roasting extraction overcomes thermal degradation, enabling reliable glucose metabolism regulation.

A supplement formulation containing medium-chain triglycerides, amino acids, and cannabinoids enhances skin protection.

XBD173 binds mitochondrial TSPO to inhibit inflammation and cellular proliferation, addressing root causes of pulmonary arterial hypertension.

Sphingosine-1-phosphate receptor agonists activate endothelial barriers to stabilize blood pressure in trauma patients.

BTK inhibitors disrupt the CXCR4-SDF-1 signaling pathway to treat malignancies, resolving the lack of effective targeted therapies.

Cicletanine activates eNOS to boost nitric oxide, resolving portal hypertension by directly lowering pressure without reducing overall blood flow.

Purified Alpinia galanga extract improves mental alertness and sustained wakefulness without the crash associated with caffeine stimulants.

A non-retinoid compound blocks RBP4-TTR interaction to lower serum retinol levels.

Nitroxide antioxidants restore deteriorating natural gene control mechanisms to increase uncoupling protein 3 expression levels.